A Non-interventional, Post-Marketing Study to Describe Outcome of Nitisinone Treatment in HT-1 Patients
Stopped No patients were prescribed to the study treatment due to the generic treatment being available.
Conditions
- Hereditary Tyrosinemia, Type I
Interventions
Sponsor
Swedish Orphan Biovitrum